Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25

AUSTIN, Texas, March 5, 2015 /PRNewswire/ -- Vermillion, Inc. VRML, a bio-analytical solutions company focused on gynecologic disease, announced today it will report fourth quarter and 2014 financial results before the market open on Wednesday, March 25, 2015, followed by an investor conference call and webcast at 8:30am Eastern.

Conference Call & Webcast:
Wednesday, March 25, 2015 at 8:30am Eastern/5:30am Pacific

Domestic:

800-753-9057

International:

913-981-5571

Conference ID:

6825678

Webcast:

Conference Call Link:  http:/public.viavid.com/player/index.php?id=113438



Replay - Available through April 8, 2015

Domestic:

877-870-5176

International:

858-384-5517

Conference ID:

6825678

 

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in gynecologic disease. The company's lead diagnostic, OVA1®, is a blood test for pre-surgical assessment of ovarian tumors for malignancy, using an innovative algorithmic approach. As the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, OVA1 represents a new class of software-based diagnostics. For additional information, including published clinical trials, visit www.vermillion.com.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
Tel 1-646-597-6983
mwood@lifesciadvisors.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vermillion-to-report-fourth-quarter-and-year-end-2014-financial-results-and-host-an-investor-conference-call-on-march-25-300045602.html

SOURCE Vermillion, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!